---
figid: PMC7348953__ijms-21-04272-g001
figtitle: Therapeutic Targeting of the Wnt Signaling Pathway
organisms:
- NA
pmcid: PMC7348953
filename: ijms-21-04272-g001.jpg
figlink: pmc/articles/PMC7348953/figure/ijms-21-04272-f001/
number: F1
caption: 'Therapeutic Targeting of the Wnt Signaling Pathway. Red letters = drug/compound
  name. Pre = pre-clinical development, Phase # = clinical trial phase. Clinical trial
  not necessarily for gynecologic malignancy. Figure generated with BioRender.'
papertitle: Wnt Signaling in Gynecologic Malignancies.
reftext: Alexandra McMellen, et al. Int J Mol Sci. 2020 Jun;21(12):4272.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9647789
figid_alias: PMC7348953__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC7348953__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7348953__ijms-21-04272-g001.html
  '@type': Dataset
  description: 'Therapeutic Targeting of the Wnt Signaling Pathway. Red letters =
    drug/compound name. Pre = pre-clinical development, Phase # = clinical trial phase.
    Clinical trial not necessarily for gynecologic malignancy. Figure generated with
    BioRender.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - TNKS
  - AXIN1
  - AXIN2
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - GSK3B
  - APC
  - PROC
  - PORCN
  - CSNK1A1
  - KRT1
  - CSNK1A1L
  - CTNNB1
  - CLK1
  - CLK2
  - CLK3
  - CLK4
  - CP
  - HNF4A
  - LRP6
  - LRP5
  - Pyrvinium
  - Pamoate
---
